Association of HPV Genotyping with HIF1-Alpha in Advanced Cervical Cancer on Response to Radiotherapy

Authors

  • Muhammad Khalif Anfasa Department of Obstetrics and Gynecology, Universitas Padjadjaran, Bandung, Indonesia https://orcid.org/0000-0003-1672-0902
  • Dodi Suardi Department of Obstetrics and Gynecology, Universitas Padjadjaran, Bandung, Indonesia
  • Siti Salima Department of Obstetrics and Gynecology, Universitas Padjadjaran, Bandung, Indonesia
  • Gatot Nyarumenteng Adhipurnawan Winarno Department of Obstetrics and Gynecology, Universitas Padjadjaran, Bandung, Indonesia
  • Birgitta Maria Dewayani Department of Anatomical Pathology, Universitas Padjadjaran, Bandung, Indonesia
  • Nurvita Trianasari Economics and Business School, Telkom University, Bandung, Indonesia
  • Edhyana Sahiratmadja Economics and Business School, Telkom University, Bandung, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2023.11129

Keywords:

Cervical cancer, HPV, HIF-1α, Radiosensitivity

Abstract

AIM: This study aims to determine the relationship between the HPV genotype in uterine cervical cancer and the expression of HIF-1α due to tissue hypoxia and its impact on radiation response.

METHODS: This study is an analytic and observational study with a cross-sectional design with the inclusion criteria in this study that was new cervical cancer Stage IIB, IIIA, IIIB, and IVA patients treated at the oncology polyclinic who had never undergone radiotherapy and would be treated with radiation.

RESULTS: Sixty patients advanced cervical cancer aged 25 to >45 years were involved patients. The majority had HPV genotype 16  infections. There was no significant relationship between treatment response and HPV genotype (HPV 16 genotype [p = 0.844], HPV 18 genotype [p = 0.161], other HPV genotypes [p = 0.108]), radiation response with HIF-1α expression (p = 0.503; OR 1.569 [0.417–5.899]), HIF1α expression with HPV genotype (HPV genotype 16 (p = 0.648; OR 1,357 [0.356–5.041]), HPV 18 genotype (p = 0.344; OR 1,458 [0.089–2.373]), and other HPV genotypes (p = 0.505; OR 1.667 [0.368–7.553]) as well as HIF-1α expression and HPV genotypes to radiation response (p > 0.05).

CONCLUSION: Cervical cancer with infection with HPV Genotype 18 tends to express HIF1α strongly and increased partial radiation response. Overall statistically, there was no significant association between infection with certain genotypes of HPV with radiation response or HIF-1α expression in tumor tissue with radiation response.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169-82. https://doi.org/10.1016/S0140-6736(18)32470-X PMid:30638582 DOI: https://doi.org/10.1016/S0140-6736(18)32470-X

Kementerian Kesehatan RI. Penyakit Kanker di Indonesia Berada Pada Urutan 8 di Asia Tenggara dan Urutan 23 di Asia. Indonesia: Kementerian Kesehatan RI; 2019.

Berek JS. Berek and Novak’s Gynecology. 15th ed. Pennsylvania, United States: Lippincott Williams and Wilkins; 2014.

Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams Gynecology. 3rd ed. New York, United States: McGraw Hill; 2016.

Ruiz FJ, Inkman M, Rashmi R, Muhammad N, Gabriel N, Miller CA, et al. HPV transcript expression affects cervical cancer response to chemoradiation. JCI Insight. 2021;6(16):e138734. https://doi.org/10.1172/jci.insight.138734 PMid:34255749 DOI: https://doi.org/10.1172/jci.insight.138734

Ferdousi J, Nagai Y, Asato T, Hirakawa M, Inamine M, Kudaka W, et al. Impact of human papillomavirus genotype on response to treatment and survival in patients receiving radiotherapy for squamous cell carcinoma of the cervix. Exp Ther Med. 2010;1(3):525-30. https://doi.org/10.3892/etm_00000083 PMid:22993571 DOI: https://doi.org/10.3892/etm_00000083

Moreno-Acosta P, Vallard A, Carrillo S, Gamboa O, Romero- Rojas A, Molano M, et al. Biomarkers of resistance to radiation therapy: A prospective study in cervical carcinoma. Radiat Oncol. 2017;12(1):120. https://doi.org/10.1186/s13014-017-0856-2 PMid:28716107 DOI: https://doi.org/10.1186/s13014-017-0856-2

Fu Z, Cheng H, Chen D, Wang F. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia. Med Sci Moni. 2015;21:318-25. https://doi.org/10.12659/MSM.893265 PMid:25623525 DOI: https://doi.org/10.12659/MSM.893265

Onuki M, Matsumoto K, Tenjimbayashi Y, Tasaka N, Akiyama A, Sakurai M, et al. Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16- positive tumors. Papillomavirus Res. 2018;6:41-5. https://doi.org/10.1016/j.pvr.2018.10.005 PMid:30347290 DOI: https://doi.org/10.1016/j.pvr.2018.10.005

Hang D, Jia M, Ma H, Zhou J, Feng X, Lyu Z, et al. Independent prognostic role of human papillomavirus genotype in cervical cancer. BMC Infect Dis. 2017;17(1):391. https://doi.org/10.1186/s12879-017-2465-y PMid:28583086 DOI: https://doi.org/10.1186/s12879-017-2465-y

Hall JS, Iype R, Armenoult LS, Taylor J, Miller CJ, Davidson S, et al. Poor prognosis associated with human papillomavirus α7 genotypes in cervical carcinoma cannot be explained by intrinsic radiosensitivity. Int J Radiat Oncol Biol Phys. 2013;85(5):e223-9. https://doi.org/10.1016/j.ijrobp.2012.11.030 PMid:23332225 DOI: https://doi.org/10.1016/j.ijrobp.2012.11.030

Ziello JE, Jovin IS, Huang Y. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 2007;80(2):51-60. PMid:18160990

Weidemann A, Johnson RS. Biology of HIF-1α. Cell Death Differ. 2008;15(4):621-7. https://doi.org/10.1038/cdd.2008.12 PMid:18259201 DOI: https://doi.org/10.1038/cdd.2008.12

Han S, Huang T, Hou F, Yao L, Wang X, Wu X. The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: A meta-analysis with trial sequential analysis. Ther Adv Med Oncol. 2019;11:1-21. https://doi.org/10.1177/1758835919875851. PMid:31579115 DOI: https://doi.org/10.1177/1758835919875851

Winata IG, Hidayat YM, Winarno GN, Suardi D, Soetopo S, Suwiyoga K. Pulsatility index and hypoxia inducible factor-1α expression predict the clinical response after external radiation in patients with stage IIB to IVA cervical cancer. Asian Pac J Cancer Prev. 2019;20(7):2073-8. https://doi.org/10.31557/apjcp.2019.20.7.2073 PMid:31350968 DOI: https://doi.org/10.31557/APJCP.2019.20.7.2073

Song L, Liu S, Zhang L, Yao H, Gao F, Xu D, et al. MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway. Tumor Biol. 2016;37(9):12161-8. https://doi.org/10.1007/s13277-016-5073-3 PMid:27220494 DOI: https://doi.org/10.1007/s13277-016-5073-3

Li N, Meng DD, Gao L, Xu Y, Tian YW, Yi ZY, et al. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression. Radiat Oncol. 2018;13(1):210. https://doi.org/10.1186/s13014-018-1153-4 PMid:30355300 DOI: https://doi.org/10.1186/s13014-018-1153-4

Qin C, Chen X, Bai Q, Davis MR, Fang Y. Factors associated with radiosensitivity of cervical cancer. Anticancer Res. 2014;34(9):4649-56. PMid:25202040

Downloads

Published

2023-02-16

How to Cite

1.
Anfasa MK, Suardi D, Salima S, Winarno GNA, Dewayani BM, Trianasari N, Sahiratmadja E. Association of HPV Genotyping with HIF1-Alpha in Advanced Cervical Cancer on Response to Radiotherapy. Open Access Maced J Med Sci [Internet]. 2023 Feb. 16 [cited 2024 Nov. 21];11(B):396-401. Available from: https://oamjms.eu/index.php/mjms/article/view/11129